AT-076
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C26H35N3O3 |
| Molar mass | 437.584 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
AT-076 is a so-called opioid "pan" antagonist and is the first reasonably balanced antagonist known of all four opioid receptor types.[1] It acts as an antagonist of all four types of opioid receptor, behaving as a competitive antagonist of the μ-opioid receptor (Ki = 1.67 nM) and δ-opioid receptor (Ki = 19.6 nM) and as a noncompetitive antagonist of the κ-opioid receptor (Ki = 1.14 nM) and nociceptin receptor (NOP, Ki = 1.75 nM).[1] AT-076 was derived from the κ-opioid receptor antagonist JDTic, which showed affinity for NOP,[2] by removal of two methyl groups from the piperidine ring. This increased affinity for NOP 10-fold relative to the parent compound.[1]
See also
[edit]References
[edit]- ^ a b c Zaveri NT, Journigan VB, Polgar WE (2015). "Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors". ACS Chemical Neuroscience. 6 (4): 646–657. doi:10.1021/cn500367b. PMC 4401318. PMID 25635572.
- ^ Munro TA, Huang XP, Inglese C, Perrone MG, Van't Veer A, Carroll FI, et al. (2013). Porter J (ed.). "Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters". PLOS ONE. 8 (8) e70701. doi:10.1371/journal.pone.0070701. PMC 3747596. PMID 23976952.
 | This analgesic-related article is a stub. You can help Wikipedia by adding missing information. |